Figure 5 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
<p>Reciprocity of drug sensitivities and gene expression signatures between trametinib and dasatinib in DIPG cells. <b>A,</b> Dose–response curves for ulixertinib tested against ICR-B169 parental cells (gray) and resistant clones T1 (<i>MEK2</i><sup>I115N</sup&...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|